BONDAVALLI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 15.535
AS - Asia 1.639
NA - Nord America 795
SA - Sud America 122
AF - Africa 15
OC - Oceania 1
Totale 18.107
Nazione #
IT - Italia 15.278
US - Stati Uniti d'America 752
SG - Singapore 720
CN - Cina 443
VN - Vietnam 293
FR - Francia 129
BR - Brasile 86
HK - Hong Kong 71
DE - Germania 36
FI - Finlandia 29
JP - Giappone 22
GB - Regno Unito 21
BD - Bangladesh 19
AR - Argentina 16
MX - Messico 14
CA - Canada 11
IN - India 11
NL - Olanda 9
PH - Filippine 7
TH - Thailandia 7
EC - Ecuador 6
ID - Indonesia 5
IE - Irlanda 5
KR - Corea 5
RU - Federazione Russa 5
VE - Venezuela 5
ZA - Sudafrica 5
CH - Svizzera 4
CO - Colombia 4
ES - Italia 4
IQ - Iraq 4
JM - Giamaica 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
HR - Croazia 3
PK - Pakistan 3
PL - Polonia 3
PR - Porto Rico 3
TR - Turchia 3
TW - Taiwan 3
BB - Barbados 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
MA - Marocco 2
NP - Nepal 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SE - Svezia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
UY - Uruguay 1
Totale 18.107
Città #
Genova 9.467
Genoa 3.470
Rapallo 1.383
Vado Ligure 896
Singapore 357
San Jose 304
Lauterbourg 121
Ho Chi Minh City 84
Beijing 70
New York 70
Hong Kong 67
Hanoi 61
Ashburn 51
Frankfurt am Main 34
Helsinki 29
Santa Clara 26
Tokyo 19
Haiphong 17
Bordighera 14
Los Angeles 12
Orem 11
São Paulo 11
Tianjin 11
Amsterdam 9
Da Nang 9
Des Moines 9
Mexico City 9
Council Bluffs 8
Memphis 8
Rome 8
Cardiff 7
Atlanta 6
Can Tho 6
Dallas 6
London 6
Biên Hòa 5
Buenos Aires 5
Chicago 5
Denver 5
Dublin 5
Milan 5
Naples 5
Boardman 4
Buffalo 4
Campinas 4
Jeddah 4
Quito 4
Shanghai 4
Toronto 4
Wuhan 4
Baghdad 3
Baku 3
Bangkok 3
Belo Horizonte 3
Bắc Ninh 3
City of London 3
Houston 3
Hải Dương 3
Johannesburg 3
Phoenix 3
Phủ Lý 3
Rio de Janeiro 3
Salvador 3
Seattle 3
Warsaw 3
Zagreb 3
Zurich 3
Amman 2
Brasília 2
Brooklyn 2
Charlotte 2
Chennai 2
Curitiba 2
Formosa 2
Guayaquil 2
Ha Long 2
Harrisburg 2
Hefei 2
Jakarta 2
Kansas City 2
Kingston 2
Lancaster 2
Langfang 2
Las Vegas 2
Long Xuyen 2
Manila 2
Mauá 2
Montego Bay 2
Moscow 2
Mumbai 2
Nairobi 2
Nha Trang 2
Paris 2
Phnom Penh 2
Poplar 2
Quảng Ngãi 2
San José 2
Shijiazhuang 2
Tashkent 2
The Dalles 2
Totale 16.860
Nome #
An efficient synthesis of functionalized 2-pyridones by direct route or via amide/enolate ammonium salt intermediates 212
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 192
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach 191
1-Acyl-, 3-acyl- and 1,3-diacyl-3-furfuryl-1-phenylthioureas with platelet antiaggregating and other activities. 181
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors 178
3-Arylsulphonyl-5-arylamino-1,3,4-thiadiazol-2(3H)ones as antiinflammatory and analgesic agents 177
Synthesis and biological evaluation of neutrophilic inflammation inhibitors 177
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity 176
. 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities. 175
A chemometric approach to predict A1 agonist effect of adenosine analogues 171
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines 170
3,5-Diphenyl-1H-pyrazole derivatives. IX. 2-substituted 4-phenyl-5-(3,5-diphenyl-1H-pyrazol-1-yl) pyrimidines with platelet antiaggregating and other activities. 168
3,5-Diphenyl-1H-pyrazole derivatives. V--1-Acetyl-4-hydroxy-3,5-diphenyl-2-pyrazoline esters, 4-hydroxy-3,5-diphenyl-1H-pyrazole esters and N-substituted 4-(3-amino-2-hydroxy-1-propoxy)-1-methyl-3,5-diphenyl-1H-pyrazoles with antiarrhythmic, sedative and platelet antiaggregating activities. 167
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 163
3,3-disubstituted 1-acyl-1-phenylthioureas with platelet antiaggregating and other activities 162
Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis 162
3,5-Diphenyl-1H-pyrazole derivatives. III. Ethers 1-(2-hydroxyethyl)-3,5-diphenyl-1H-pyrazole and its 4-bromo derivative with hypotensive, depressant, antiarrhythmic and analgesic activities 159
Synthesis and pharmacological activity of derivatives of exo- trimethylenenorbornane. I 157
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis 156
2- And 5-substituted 5-amino-2,6,6-trimethyltetrahydropyrans 155
Derivati dell'1,3-benzodiossolo, potenziali inibitori delle PDE5 153
N'-acyl-N,N-(1,3,3-trimethylbicyclo [2.2.1]hept-2-ylidene)benzamidines with hypotensive activity. 153
Synthesis and reactivity of (1S,4S,5S) -5-bromo-1,3,3-trimethyl-N-nitro-2-oxabicyclo[2.2.2]octan-6-imine. X Ray-molecular structure and absolute configuration of E and Z isomers of (1S,4S)-5,5-dibromo-1,3,3-trimethyl-N-nitro-2-oxabicyclo[2.2.2]octan-6-imine, the first case of separated nitrimine isomers. 151
2-aryl-3-phenylamino-4,5-dihydro-2H-benz[g]indazoles with antiarrhythmic and local anaesthetic activities 151
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation 151
3-(Arylamino)-6,7-dihydro-6-methylpyrano[4,3-c]pyrazol-4(1H or 2H)-ones with antipyretic, analgesic, antiarrhythmic, hypotensive and other activities. 150
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 150
Carbonyl transposition and regio- and stereo-specific syntheses of new alcohols, amino-alcohols and ketones in the monoterpenoid 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane 150
Antiinflammatory agents: new series of N-substituted amino acids with complex pyrimidine structures endowed with antiphlogistic activity 150
Synthesis, molecular modeling studies and pharmacological activity of selective A1 receptor antagonists 149
N-Acyl-N-phenyl ureas of piperidine and substituted piperidines endowed with antiinflammatory and antiproliferative activities 149
Synthesis and pharmacological evaluation of 5H-[1]benzopyrano[4,3-d]pyrimidines effective as antiplatelet/analgesic agents 147
4-Amino-pyrazolo[3,4-d]pyrimidines with antiproliferative activity on osteosarcoma cell line SaOS-2 144
N-acyl-N'-methyl-N-(1,3,3-trimethylbicyclo[2.2.1]hept-2-yl) benzamidines with hypotensive activity. 143
3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities. 143
Unprecedented one-pot stereoselective synthesis of Knoevenagel-type derivatives via in situ condensation of N-methyleniminium salts of ethylenethiourea and ethyleneurea with active methylene reagents 142
2-Aryl-6-methyl-3-phenylamino-6,7-dihydropyrano[4,3-c]pyrazol-4(2H)-ones with analgesic activity. 142
New halogenated 4-aminopyrazolo[3,4-b]pyridines A1 adenosine receptor ligands 140
Exploring the molecular basis of selectivity in A1 adenosine receptors antagonist: a case study 140
3,5-Diphenyl-1H-pyrazole derivatives. I--Esters and N-substituted carbamates of 1-(2-hydroxyethyl)-3,5-diphenyl-1H-pyrazole and its 4-bromo derivative with depressant, antiarrhythmic, analgesic and other activities. 139
3,5-Diphenyl-1H-pyrazole derivatives. II--N-substituted 1-(2-aminoethyl)-3,5-diphenyl-1H-pyrazoles and their 4-bromo derivatives with analgesic and other activities 139
Structure-based Design, Parallel Synthesis, SAR and Molecular Modelling Studies of Thiocarbamates, New Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Isosteres of Phenethylthiazolylthiourea Derivatives. 137
3,5-Diphenyl-1H-pyrazole derivatives. VI Esters and 2-dialkylaminoethyl ethers of 1(2-hydroxy-2-phenylethyl)-3,5-diphenyl-1H-pyrazole and N,N-disubstituted 1-(2-amino-2-phenylethyl)-3,5-diphenyl-1H-pyrazoles with depressant and platelet antiaggregating activities. 137
Antiangiogenic agents: an update on small molecule VEGFR inhibitors 136
2,3-Dihydro-1H-imidazo[1,2-b]pyrazole derivatives as potential neutrophils functions inhibitors 136
omega-Dialkylaminoalkyl esters of 3-dialkylamino-4,7,7-trimethyl-N-phenylbicyclo[2.2.1] hept-2-ene-2-iminothiolic acids with local anesthetic activity. 136
Preparation of new 5-aroylamino substituted 3-nicotinoyl/isonicotinoyl-1,3,4-thiadiazol-2(3H)-ones with anti-inflammatory activity 135
5-alkoxy-2-hydrazino and 5-methoxy-2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 135
Synthesis and pharmacological evaluation of 2,5-Cycloamino-5H[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activity 135
3,5-Diphenyl-1H-pyrazole derivatives. VII--Esters, 2-dialkylaminoethyl ethers and N-substituted carbamates of 1-(2-hydroxy-3-phenoxypropyl)-3,5-diphenyl-1H-pyrazole with depressant and platelet antiaggregating activities 134
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model. 133
3,5-Diphenyl-1H-pyrazole derivatives. XII. N-substituted 4-amino-1-(2-hydroxy- or 2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazoles with local anesthetic, analgesic and platelet antiaggregating activities. 133
Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities. 130
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 129
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1-H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation 128
4-Amino-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and their preparation, pharmaceutical composistion and use antitumor and antileukemic agents 128
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells 128
Derivatives of 4,5,6,7-Tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-Indazole with hypoglycemic and hypotensive activities 128
New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities 128
3,5-Diphenyl-1H-pyrazole derivatives. VIII. N-substituted 3-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)-propanamides, -propanamines and 2-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)ethanamines with platelet antiaggregating, hypotensive, antiarrhythmic and other activities. 127
Synthesis and anti-inflammatory activity of esters derived from 5-aryl-1,2-dihydro-2-(2-hydroxyethyl)-3H-1,2,4-triazole-3-thiones 127
N-Substituted O-(3-amino-2-hydroxypropyl)oximes of 1,3,3-trimethyl-5-endo-(1-piperidinyl or 4-morpholinyl)-2-oxabicyclo[2.2.2]octan-6-ones with platelet antiaggregating and local anesthetic activities 126
Derivatives of 5,7,7-trimethyl-6-oxa-3-azabicyclo[3.2.2]nonane with antiarrhythmic, local anesthetic and hypotensive activities. II 126
The reaction of Terpenoid Nitrimines with secondary amines; a new route to Terpenoid Enamines 125
Derivatives of 5,7,7-trimethyl-6-oxa-3-azabicyclo[3.2.2]nonane with antiarrhythmic, local anesthetic and hypotensive activities 125
5-[[ω-(Dialkylamino)alkoxy]methylene]-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-ones with hypotensive, local anesthetic, antiarrhythmic and other activities 125
Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives 124
New pyrazolo[3,4-b]pyridones as selective A1 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies 121
Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4,3-d]pyrimidin-5-ones  121
Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands 120
Reduction of 6-hydroxyimino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane and nitrosation of the resulting amines. New rearrangement products of the monoterpenoid 1,3,3-trimethyl-2-oxabicyclo [2.2.2]octane 120
O-[2-Hydroxy-3-(dialkylamino)propyl]ethers of (+)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one oxime (camphor oxime) with analgesic and antiarrhythmic activities 119
N-acyl-4,7,7-trimethyl-N-phenyl-3-(1-piperidinyl or dimethylamino)bicyclo[2.2.1]hept-2-ene-2-carbothioamides with platelet antiaggregating and other activities. 118
Modulazioni Strutturali in O-[2-(N-Ftalimmido)etil] Acil(Aril)Tiocarbammati, Inibitori Non-Nucleosidici della Transcrittasi Inversa di HIV-1 117
null 117
Synthesis of 3-Cyclopentyloxy-4-methoxy-N-(cycloalkylamino-1-yl)-benzamides and related compounds as new Rolipram-analogues 117
N-Substituted 3-(arylamino)-4,5-dihydro-2H-benz[g]indazol-2-yl acetamides with antiinflammatory and analgesic activities 116
Bamford-Stevens reaction of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-one p-tolylsulphonylhydrazone 116
Synthesis of new pyrazolo [3,4-d]pyrimidines Bcr-Abl tyrosine kinase inhibitors 116
null 116
Syntheses of 1,3,3-trimethyl-2-oxabicyclo[2.2.2]oct-5-ene(2,3-didehydro-1, 8-cineole), 6,6-dimethyl-2-methylene-7-oxabicyclo[3.2.1]octane (Isopinol), 2,6,6-trimethyl-7-oxabicyclo[1.2.1]oct-2-ene (Pinol) and 1-(3-isopropylidenecyclopentyl)ethanone (Pinolone) from hydroxy- and bromo-derivatives of Cineole 116
Synthesis of new 2-phenyl-1-arylcarbamoyl-2,3-dihydro-1h-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 115
3,5-Diphenyl-1H-pyrazole derivatives. X. N-substituted 1-(2-aminopropyl)- and 1-(3-amino-2-hydroxypropyl)-3,5-diphenyl-1H-pyrazoles with antiinflammatory and other activities. 115
5-Substituted 2,3-dihydro-6-mercapto-1,3-diphenyl-2-thioxo-4(3H)-pyrimidinones and their 6-(acylthio) derivatives with platelet antiaggregating, antiinflammatory, antiarrhythmic, antihyperlipidemic and other activities. 114
Progress in 5H-[1]benzopyrano[4,3-d]pyrimidin-5-amine series: 2-methoxy derivatives effective as antiplatelet agents with analgesic activity 114
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines 114
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 113
New pyrazolo[3,4-d]pyrimidines 4-benzylamino substituted endowed with antiproliferative activity on chronic myeloid leukemia cell line 113
New rolipram related PDE4 inhibitors: synthesis, enantiomers separation and enzymatic activity 113
N-arylsubstituted-1-aryl-3,4-diphenyl-5-pyrazole amines with analgesic and antiarrhythmic properties. 113
New selective PDE4D inhibitors able to discriminate between long, short and supershort isoforms 112
Synthesis of pyrazolo[3,4-d]pyridines selective antagonists of A1 adenosine receptors 111
Esters of 6-Cis-dialkyilamino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-5-trans-ols with hypotensive and other activities 111
Reactions of the potassium salt of 1,7,7-trimethyl-N-nitrobicyclo[2.2.1] heptan-2-imine with bromine and nitrous acid: Synthesis of 3-exo-bromo-1,7,7-trimethyl-N-nitrobicyclo[2.2.1]heptan-2-imine, 3-endo-bromo-1,7,7-trimethyl-N-nitrobicyclo[2.2.1]heptan-2-imine, 1,7,7-trimethyl-N-nitro-3-nitrosobicyclo[2.2.1]hept-2-en-2-amine and their reactions with nitrogen nucleophiles. 111
N-Monosubstituted Urethanes and Esters of 6-cis-Dimethylamino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-5-trans-ol with hypotensive and other activities 110
Preparation of ureidopyrazolecarboxylates with neutrophil chemotaxis inhibiting activity. 109
N-substituted ureas of ethyl 1-(2-hydroxy-2-phenylethyl)-1H-pyrazole-4-carboxylate as potent and selective IL-8 receptor inhibitors 109
3-Hydroxyiminocamphornitrimine and Camphorquinone Dinitrimine, Compounds previously described as N-Nitro-3-nitrosocamphorenamine.and N-Nitro-N,3-Dinitrosocamphorenamine. Crystal Structure of Camphorquinone Dinitrimine. 109
ω-Dialkylaminoalkyl ethers of 6-(benzyl or phenyl)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-ol with platelet antiaggregating and local anesthetic activities 108
Derivatives of 1,3,3-Trimethyl-6-azabicyclo[3.2.1]octane with hypotensive activity 108
Totale 13.688
Categoria #
all - tutte 55.681
article - articoli 44.784
book - libri 0
conference - conferenze 9.207
curatela - curatele 0
other - altro 0
patent - brevetti 1.690
selected - selezionate 0
volume - volumi 0
Totale 111.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/20221.646 31 154 95 250 54 110 158 348 40 128 79 199
2022/20231.667 181 101 16 170 320 307 0 113 275 11 152 21
2023/2024808 39 134 12 100 76 159 30 27 57 7 43 124
2024/20252.196 33 185 66 164 285 240 141 331 85 93 242 331
2025/20263.983 524 87 256 352 525 468 706 168 238 452 189 18
Totale 18.212